We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.32B
AUM Growth
-$106M
Cap. Flow
-$178M
Cap. Flow %
-13.42%
Top 10 Hldgs %
3.73%
Holding
2,115
New
538
Increased
461
Reduced
531
Closed
578

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$5.58M
2
DVN icon
Devon Energy
DVN
+$4.57M
3
STT icon
State Street
STT
+$4.35M
4
IEX icon
IDEX
IEX
+$4.05M
5
SN icon
SharkNinja
SN
+$3.73M

Sector Composition

Rank Sector Weight
1 Technology 16.98%
2 Healthcare 13.84%
3 Consumer Discretionary 13.31%
4 Financials 12.89%
5 Industrials 11.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVX
1451
Innovex International
INVX
$1.97B
$147K 0.01%
10,042
-14,226
-59% -$228K
LUNA
1452
DELISTED
Luna Innovations Incorporated
LUNA
$144K 0.01%
+61,460
New +$157K
VNDA icon
1453
Vanda Pharmaceuticals
VNDA
$302M
$143K 0.01%
+30,423
New +$163K
AFCG
1454
AFC Gamma
AFCG
$63.4M
$140K 0.01%
+13,721
New +$133K
GILT icon
1455
Gilat Satellite Networks
GILT
$848M
$140K 0.01%
+26,549
New +$122K
CIG icon
1456
CEMIG Preferred Shares
CIG
$6.01B
$139K 0.01%
+67,455
New +$135K
RKLB icon
1457
Rocket Lab Corp
RKLB
$51.8B
$139K 0.01%
+14,328
New +$87K
LCUT icon
1458
Lifetime Brands
LCUT
$211M
$137K 0.01%
20,936
-6,054
-22% -$44.5K
SGHT icon
1459
Sight Sciences
SGHT
$412M
$136K 0.01%
+21,514
New +$145K
PTVE
1460
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$136K 0.01%
11,796
-24,611
-68% -$282K
ZIP icon
1461
ZipRecruiter
ZIP
$423M
$134K 0.01%
+14,053
New +$126K
TPST icon
1462
Tempest Therapeutics
TPST
$14.6M
$133K 0.01%
7,301
-472
-6% -$9.67K
CSPI icon
1463
CSP Inc
CSPI
$82.1M
$131K 0.01%
10,094
-2,001
-17% -$28.1K
TDUP icon
1464
ThredUp
TDUP
$422M
$131K 0.01%
155,554
-166,102
-52% -$203K
VMD icon
1465
Viemed Healthcare
VMD
$371M
$131K 0.01%
17,836
+4,829
+37% +$34.5K
CXM icon
1466
Sprinklr
CXM
$1.61B
$129K 0.01%
+16,642
New +$147K
CABA icon
1467
Cabaletta Bio
CABA
$455M
$127K 0.01%
+26,976
New +$156K
DRH icon
1468
Diamondrock Hospitality Co
DRH
$2.56B
$126K 0.01%
+14,449
New +$122K
HLVX
1469
DELISTED
HilleVax
HLVX
$126K 0.01%
+71,463
New +$183K
PBYI icon
1470
Puma Biotechnology
PBYI
$454M
$126K 0.01%
49,494
-140,257
-74% -$425K
NN icon
1471
NextNav
NN
$2.23B
$125K 0.01%
+16,709
New +$129K
OPRT icon
1472
Oportun Financial
OPRT
$372M
$122K 0.01%
43,293
-204
-0.5% -$592
NPKI
1473
NPK International
NPKI
$1.14B
$122K 0.01%
17,618
+7,140
+68% +$54.9K
CMPX icon
1474
Compass Therapeutics
CMPX
$387M
$121K 0.01%
65,922
STTK icon
1475
Shattuck Labs
STTK
$694M
$121K 0.01%
+34,699
New +$129K

Similar funds

GSA Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, GSA Capital Partners held 2,115 positions worth $1.32B, down 7.4% from $1.43B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners withdrew a net $178M in Q3 2024, closing 578 positions and reducing 531 holdings. Its most notable exit was State Street, an estimated $4.35M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Idacorp worth $3.23M.

  • GSA Capital Partners's largest Q3 2024 buy was Idacorp: 31,311 shares worth $3.23M.
  • GSA Capital Partners added most to Hudson Pacific Properties in Q3 2024, an estimated $3.7M increase.
  • GSA Capital Partners's biggest Q3 2024 reduction was Fiserv Inc, cutting an estimated $5.58M.
  • GSA Capital Partners fully exited State Street in Q3 2024, selling an estimated $4.35M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $1.32B portfolio in Q3 2024.
  • GSA Capital Partners opened 538 new positions and closed 578 in Q3 2024.
  • GSA Capital Partners's portfolio value fell 7.4% quarter-over-quarter to $1.32B.

Based on GSA Capital Partners's 13F filing for Q3 2024, filed 5 Nov 2024.